Pages that link to "Q42112284"
Jump to navigation
Jump to search
The following pages link to DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients (Q42112284):
Displaying 25 items.
- DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes (Q21558457) (← links)
- Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy (Q26751035) (← links)
- Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges (Q26823070) (← links)
- Epigenetic Biomarkers in Colorectal Cancer (Q30240778) (← links)
- Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism (Q34000439) (← links)
- Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma (Q34486212) (← links)
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers (Q34487177) (← links)
- Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis (Q35567859) (← links)
- Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update (Q35726371) (← links)
- Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis (Q35964783) (← links)
- DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer (Q37055333) (← links)
- Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer (Q37578728) (← links)
- Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review (Q38321611) (← links)
- Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study (Q45362780) (← links)
- Colorectal cancer: epigenetic alterations and their clinical implications. (Q46112381) (← links)
- DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies (Q46181764) (← links)
- Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives (Q49663292) (← links)
- Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. (Q52802632) (← links)
- Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. (Q54232902) (← links)
- Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India) (Q90095282) (← links)
- Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis (Q90414169) (← links)
- Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients (Q92094915) (← links)
- PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis (Q92369113) (← links)
- Multiple gene promoter methylation and clinical stage in adjacent normal tissues: Effect on prognosis of colorectal cancer in Taiwan (Q92563781) (← links)
- O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications (Q92745107) (← links)